Vasconcelos, Amanda D.
Donado-Pestana, Carlos M.
More, Tushar H.
Duarte, Graziela B. S.
Duarte, Stephany G.
Dias, Caroline G.
Rodrigues, Larissa
Hernandez, Guilherme N.
Fock, Ricardo
Hiller, Karsten
Fiamoncini, Jarlei http://orcid.org/0000-0002-8456-983X
Funding for this research was provided by:
Fundação de Amparo à Pesquisa do Estado de São Paulo (2019/24311-1, 20/16542-0, 13/07914-8, 22/02941-6, 21/08657-5)
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (88887.684161/2022-00)
Conselho Nacional de Desenvolvimento Científico e Tecnológico (#403677/2021-1)
Article History
Received: 4 September 2023
Accepted: 17 November 2023
First Online: 1 July 2024
Declarations
:
: This study was conducted according to the guidelines of the Declaration of Helsinki and was approved by the Ethics Committee of the Faculty of Pharmaceutical Sciences (CAAE: 15438019.7.0000.0067) and by the Ethics Committee of the University Hospital of the University of São Paulo (CAAE: 15438019.7.3001.0076). It was registered at The Brazilian Registry of Clinical Trials (ReBEC) with the code RBR-3vgndbw. Written informed consent was obtained from all participants.
: Not applicable.
: The authors declare no conflict of interest.